Top Buy
| Security | Buy | Sell | Buy (1W) ▼ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Neurocrine Bioscience | 31 | 0 | 2 | 0 | €126.20 | €140.60 | 11.413% |
| Medpace Holdings Inc | 11 | 0 | 2 | 0 | €355.90 | €419.64 | 17.909% |
| Amicus Therapeutics Inc. | 7 | 0 | 1 | 0 | €9.15 | €17.64 | 92.762% |
| United Therapeutics | 19 | 0 | 0 | 0 | €250.00 | €287.40 | 14.960% |
| Exelixis Inc. | 18 | 0 | 0 | 0 | €19.20 | €26.01 | 35.485% |
| Alnylam Pharmace. | 36 | 0 | 0 | 0 | €138.50 | €236.30 | 70.612% |
| Halozyme Therapeutics Inc. | 15 | 0 | 0 | 0 | €39.58 | €47.17 | 19.176% |
| Nektar Therapeutics | 3 | 1 | 0 | 0 | €1.17 | €3.70 | 216.781% |
| PTC Therapeutics Inc. | 15 | 8 | 0 | 1 | €31.80 | €41.51 | 30.542% |
| Agios Pharmaceuticals Inc. | 6 | 0 | 0 | 0 | €34.80 | €38.99 | 12.036% |
| Xencor Inc. | 10 | 1 | 0 | 0 | €21.20 | €32.58 | 53.674% |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 0 | 0 | €35.40 | €84.74 | 139.390% |
| Blueprint Medicines Corp | 2 | 0 | 0 | 0 | €98.16 | - | - |
| Novocure Ltd | 1 | 1 | 0 | 0 | €20.57 | - | - |
| Repligen Corp. | 13 | 0 | 0 | 0 | €136.80 | €184.76 | 35.058% |